Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore

被引:8
|
作者
Hackman, Jada [1 ]
Falade-Nwulia, Oluwaseun [2 ]
Patel, Eshan U. [3 ]
Mehta, Shruti H. [2 ]
Kirk, Gregory D. [2 ,4 ]
Astemborski, Jacquie [2 ]
Ray, Stuart C. [4 ]
Thomas, David L. [2 ,4 ]
Laeyendecker, Oliver [1 ,2 ,4 ]
机构
[1] NIAID, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
Hepatitis C virus; 1CE; Phylogenetic; Molecular epidemiology; PWID; Injection drug use; HUMAN-IMMUNODEFICIENCY-VIRUS; RISK-FACTORS; HCV INFECTION; NEW-YORK; TRANSMISSION; USERS; HIV; PREVALENCE; VANCOUVER; NETWORK;
D O I
10.1016/j.meegid.2019.104078
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study examines correlates of hepatitis C virus (HCV) genetic clustering among community-recruited people who inject drugs enrolled in the AIDS Linked to the IntraVenous Experience cohort in Baltimore between 1988 and 1989. HCV RNA was extracted and the core/envelope-1 region was sequenced. Clusters were identified from maximum likelihood trees with 1000 bootstrap replicates using a 70% aLRT and a 4% genetic-distance threshold in Cluster Picker. Overall, 46% of participants were in a cluster, including 122 genotype-1a and 36 genotype-1b clusters with an average of 2-3 genetically linked HCV infections. The largest cluster consists of 9 participants. In univariable analysis, black race (PR= 1.66 [95% CI: 1.12-2.45]), age < 35 years (PR= 1.18 [95% CI: 1.02-1.37]), and injection drug use of cocaine alone (PR= 1.30 [95% CI: 1.02-1.65]) were significantly associated with being in a cluster. Conversely, a history of medication-associated treatment (MAT) was negatively associated with being in a cluster (PR= 0.82 [95% CI: 0.71-0.95]). In multivariable analysis, black race (APR = 1.62 [95% CI: 1.11-2.38]) remained independently associated being in a cluster while MAT (APR = 0.85 [95% CI: 0.74-0.99]) remained negatively associated with clustering. Our findings suggest strong locally-propagated transmission networks during the early epidemic that was driven by younger PWID. In light of the current opioid epidemic in the US, these findings suggest an urgent need for preventive interventions to mitigate the growth of large HCV transmission networks.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Predictors of future overdose among people who inject drugs in Baltimore, Maryland
    Ramirez, Michael P.
    Lucas, Gregory M.
    Page, Kathleen R.
    Zook, Katie
    Landry, Miles
    Rosecrans, Amanda
    Harris, Robert
    Grieb, Suzanne M.
    Falade-Nwulia, Oluwaseun
    Clarke, William
    Sherman, Susan G.
    Weir, Brian W.
    DRUG AND ALCOHOL DEPENDENCE REPORTS, 2024, 13
  • [32] Engagement in treatment for depression among people who inject drugs in Baltimore, Maryland
    Genberg, Becky L.
    Astemborski, Jacquie
    Treisman, Glenn
    Anagnostopoulos, Alexia
    Mehta, Shruti H.
    Kirk, Gregory D.
    Abraham, Alison
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2019, 106 : 107 - 112
  • [33] HEPATITIS C CLEARANCE AND REINFECTION IN A COHORT OF PEOPLE WHO INJECT DRUGS: BEHAVIOURAL AND GENETIC CORRELATES
    Sacks-Davis, Rachel
    Aitken, Campbell
    Higgs, Peter
    Spelman, Timothy
    Pedrana, Alisa
    Bowden, Scott
    Bharadwaj, Mandvi
    Nivarthi, Usha
    Suppiah, Vijay
    George, Jacob
    Drummer, Heidi E.
    Hellard, Margaret
    HEPATOLOGY, 2011, 54 : 1180A - 1180A
  • [34] Transmission of Hepatitis C Virus Among People Who Inject Drugs: Viral Stability and Association With Drug Preparation Equipment
    Doerrbecker, Juliane
    Behrendt, Patrick
    Mateu-Gelabert, Pedro
    Ciesek, Sandra
    Riebesehl, Nina
    Wilhelm, Corinne
    Steinmann, Joerg
    Pietschmann, Thomas
    Steinmann, Eike
    JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (02): : 281 - 287
  • [35] Experience with viral hepatitis C treatment among people who inject drugs and participate in a methadone substitution treatment program
    Krekulova, L.
    Vavrincikova, L.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2021, 70 (01): : 18 - 25
  • [36] Recommendations for the management of hepatitis C virus infection among people who inject drugs
    Grebely, Jason
    Robaeys, Geert
    Bruggmann, Philip
    Aghemo, Alessio
    Backmund, Markus
    Bruneau, Julie
    Byrne, Jude
    Dalgard, Olav
    Feld, Jordan J.
    Hellard, Margaret
    Hickman, Matthew
    Kautz, Achim
    Litwin, Alain
    Lloyd, Andrew R.
    Mauss, Stefan
    Prins, Maria
    Swan, Tracy
    Schaefer, Martin
    Taylor, Lynn E.
    Dore, Gregory J.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2015, 26 (10) : 1028 - 1038
  • [37] Modeling Hepatitis C Elimination Among People Who Inject Drugs in New Hampshire
    Blake, Andrew
    Smith, James E.
    JAMA NETWORK OPEN, 2021, 4 (08) : E2119092
  • [38] People with Hepatitis C Who Inject Drugs - Underserved, Not Undeserving
    Dore, Gregory J.
    Trooskin, Stacey
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07): : 608 - 611
  • [39] Mitigating the burden of hepatitis C virus among people who inject drugs in Belgium
    Mathei, Catharina
    Bourgeois, Stefan
    Blach, Sarah
    Brixko, Christian
    Mulkay, Jean-Pierre
    Razavi, Homie
    Robaeys, Geert
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2016, 79 (02): : 227 - 232
  • [40] Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
    Robaeys, Geert
    Grebely, Jason
    Mauss, Stefan
    Bruggmann, Philip
    Moussalli, Joseph
    De Gottardi, Andrea
    Swan, Tracy
    Arain, Amber
    Kautz, Achim
    Stoever, Heino
    Wedemeyer, Heiner
    Schaefer, Martin
    Taylor, Lynn
    Backmund, Markus
    Dalgard, Olav
    Prins, Maria
    Dore, Gregory J.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 : S129 - S137